Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (51-60 of 318) with videos related to

Pageof 32
Sort By:
Hepatology (Baltimore, Md.)|July 28, 2007
Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesisNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2016
Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodulesYusuke Kawamura, Kenji Ikeda, Shunichiro Fujiyama, et al.
Journal of Medical Virology|June 4, 2016
Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and olderNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.
Journal of Medical Virology|August 21, 2015
Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infectionNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.
Internal Medicine (Tokyo, Japan)|June 20, 2017
New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver DiseaseYusuke Kawamura, Kenji Ikeda, Yasuji Arase, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 4, 2016
Beneficial effect of arterial embolization with warmed miriplatin for multiple hepatocellular carcinomaKenji Ikeda, Yusuke Kawamura, Masahiro Kobayashi, et al.
Gut and Liver|November 28, 2015
Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in JapanNorio Akuta, Yusuke Kawamura, Yasuji Arase, et al.
Oncology|August 31, 2023
Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver CancerNorio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, et al.
Journal of Gastroenterology and Hepatology|March 3, 2005
Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis BAkihito Tsubota, Yasuji Arase, Yoshiyuki Suzuki, et al.
Journal of Medical Virology|August 21, 2007
Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infectionYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
Pageof 32

Showing results (51-60 of 318) with videos related to

Sort By:
Pageof 32
Hepatology (Baltimore, Md.)|July 28, 2007
Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesisNorio Akuta, Fumitaka Suzuki, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 2, 2016
Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodulesYusuke Kawamura, Kenji Ikeda, Shunichiro Fujiyama, et al.
Journal of Medical Virology|June 4, 2016
Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and olderNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.
Journal of Medical Virology|August 21, 2015
Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infectionNorio Akuta, Hitomi Sezaki, Fumitaka Suzuki, et al.
Internal Medicine (Tokyo, Japan)|June 20, 2017
New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver DiseaseYusuke Kawamura, Kenji Ikeda, Yasuji Arase, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 4, 2016
Beneficial effect of arterial embolization with warmed miriplatin for multiple hepatocellular carcinomaKenji Ikeda, Yusuke Kawamura, Masahiro Kobayashi, et al.
Gut and Liver|November 28, 2015
Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in JapanNorio Akuta, Yusuke Kawamura, Yasuji Arase, et al.
Oncology|August 31, 2023
Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver CancerNorio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, et al.
Journal of Gastroenterology and Hepatology|March 3, 2005
Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis BAkihito Tsubota, Yasuji Arase, Yoshiyuki Suzuki, et al.
Journal of Medical Virology|August 21, 2007
Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infectionYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
Pageof 32